- Home
- KO vs ABT Comparison
KO vs ABT Comparison
Compare KO & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KO
- ABT
- Stock Information
- Founded
- KO 1886
- ABT 1888
- Country
- KO United States
- ABT United States
- Employees
- KO N/A
- ABT N/A
- Industry
- KO Beverages (Production/Distribution)
- ABT Medical/Dental Instruments
- Sector
- KO Consumer Staples
- ABT Health Care
- Exchange
- KO Nasdaq
- ABT Nasdaq
- Market Cap
- KO 288.4B
- ABT 233.7B
- IPO Year
- KO 1919
- ABT N/A
- Fundamental
- Price
- KO $66.41
- ABT $134.56
- Analyst Decision
- KO Strong Buy
- ABT Strong Buy
- Analyst Count
- KO 13
- ABT 19
- Target Price
- KO $77.08
- ABT $143.68
- AVG Volume (30 Days)
- KO 17.1M
- ABT 4.9M
- Earning Date
- KO 10-22-2025
- ABT 10-15-2025
- Dividend Yield
- KO 3.07%
- ABT 1.75%
- EPS Growth
- KO 14.64
- ABT 151.50
- EPS
- KO 2.82
- ABT 7.97
- Revenue
- KO $47,062,000,000.00
- ABT $43,109,000,000.00
- Revenue This Year
- KO $6.11
- ABT $7.60
- Revenue Next Year
- KO $5.74
- ABT $7.84
- P/E Ratio
- KO $23.55
- ABT $16.89
- Revenue Growth
- KO 1.28
- ABT 5.85
- 52 Week Low
- KO $60.62
- ABT $110.86
- 52 Week High
- KO $74.38
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- KO 35.40
- ABT 58.17
- Support Level
- KO $66.06
- ABT $130.96
- Resistance Level
- KO $67.13
- ABT $134.96
- Average True Range (ATR)
- KO 0.85
- ABT 2.47
- MACD
- KO -0.17
- ABT 0.18
- Stochastic Oscillator
- KO 10.29
- ABT 94.67
About KO Coca-Cola Company (The)
Founded in 1886, Atlanta-headquartered Coca-Cola is the world's largest nonalcoholic beverage company, with a strong portfolio of 200 brands covering key categories including carbonated soft drinks, water, sports, energy, juice, and coffee. Together with bottlers and distribution partners, the company sells finished beverage products bearing Coca-Cola and licensed brands through retailers and food-service locations in more than 200 countries and regions globally. Coca-Cola generates around two thirds of its total revenue overseas, with a significant portion from emerging economies in Latin America and Asia-Pacific.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.